Expression and Clinical Significance of Cyclin Kinase Subunit 2 in Colorectal Cancer

Overview

Journal Oncol Lett

Specialty Oncology

Date 2013 Oct 19

PMID 24137409

Citations 9

Authors

Minhao Yu

Ming Zhong

Zhongdong Qiao

Affiliations

Soon will be listed here.

Abstract

The overexpression of cyclin kinase subunit 2 (CKS2) is tightly correlated with tumor aggressiveness and prognosis in various malignancies, including gastric, breast, liver and prostate cancer. However, whether CKS2 is upregulated in colorectal cancer (CRC) remains unknown. The aim of the present study was to analyze CKS2 expression levels in CRC, and to determine the clinical diagnostic and prognostic values of CKS2 overexpression in CRC patients. CKS2 expression was analyzed at the mRNA and protein levels by quantitative (q)PCR and western blot analysis. CKS2 expression was significantly upregulated in CRC compared with the adjacent non-cancer and normal colorectal tissues. The overexpression of CKS2 was correlated with poor differentiation and the pathological stage. In addition, CKS2 overexpression was correlated with aggressive tumor progression in CRC, which indicated that CKS2 may serve as a good CRC biomarker.

Citing Articles

Biological functions and therapeutic potential of CKS2 in human cancer.

Lai Y, Lin Y Front Oncol. 2024; 14:1424569.

PMID: 39188686 PMC: 11345170. DOI: 10.3389/fonc.2024.1424569.

Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment.

Zhi R, Hao P, Li W, Zhao H J Hepatocell Carcinoma. 2023; 10:1767-1784.

PMID: 37841370 PMC: 10572409. DOI: 10.2147/JHC.S427624.

Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome.

Rakic A, Anicic R, Rakic M, Nejkovic L J Pers Med. 2023; 13(6).

PMID: 37373974 PMC: 10302315. DOI: 10.3390/jpm13060985.

Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma.

Mo C, Wu Y, Ma J, Xie L, Huang Y, Xu Y BMC Med Genomics. 2022; 15(1):81.

PMID: 35410253 PMC: 9004629. DOI: 10.1186/s12920-022-01234-8.

Identification of core genes associated with prostate cancer progression and outcome via bioinformatics analysis in multiple databases.

Wang Y, Wang J, Yan K, Lin J, Zheng Z, Bi J PeerJ. 2020; 8:e8786.

PMID: 32266115 PMC: 7120053. DOI: 10.7717/peerj.8786.

References

Martinsson-Ahlzen H, Liberal V, Grunenfelder B, Chaves S, Spruck C, Reed S . Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells. Mol Cell Biol. 2008; 28(18):5698-709. PMC: 2546922. DOI: 10.1128/MCB.01833-07. View

Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A . Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 2009; 101(19):1308-24. PMC: 2758310. DOI: 10.1093/jnci/djp280. View

Kawakami K, Enokida H, Tachiwada T, Gotanda T, Tsuneyoshi K, Kubo H . Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep. 2006; 16(3):521-31. View

Liu Z, Fu Q, Lv J, Wang F, Ding K . Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. J Exp Clin Cancer Res. 2008; 27:51. PMC: 2579281. DOI: 10.1186/1756-9966-27-51. View

Le Voyer T, Sigurdson E, Hanlon A, Mayer R, Macdonald J, Catalano P . Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003; 21(15):2912-9. DOI: 10.1200/JCO.2003.05.062. View

Shen D, Fang Z, You P, Liu P, Wang F, Huang C . Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. Liver Int. 2009; 30(1):119-25. DOI: 10.1111/j.1478-3231.2009.02106.x. View

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

Lan Y, Zhang Y, Wang J, Lin C, Ittmann M, Wang F . Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer. 2008; 123(3):543-51. PMC: 3262990. DOI: 10.1002/ijc.23548. View

Kang M, Kim J, Kim J, Kim S, Kim Y, Yeom Y . Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer. J Cancer Res Clin Oncol. 2008; 135(6):761-9. DOI: 10.1007/s00432-008-0510-3. View

10.

Shapira M, Ben-Izhak O, Linn S, Futerman B, Minkov I, Hershko D . The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer. 2005; 103(7):1336-46. DOI: 10.1002/cncr.20917. View

11.

Slotky M, Shapira M, Ben-Izhak O, Linn S, Futerman B, Tsalic M . The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res. 2005; 7(5):R737-44. PMC: 1242136. DOI: 10.1186/bcr1278. View

12.

Alhasan S, Ensley J, Sarkar F . Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int J Oncol. 2000; 16(2):333-8. View

13.

Williams R, Wu L, Tolo V, Hall F . Identification of a novel cyclin-like protein in human tumor cells. J Biol Chem. 1993; 268(12):8871-80. View

14.

Hansel D, Dhara S, Huang R, Ashfaq R, Deasel M, Shimada Y . CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. Am J Surg Pathol. 2005; 29(3):390-9. DOI: 10.1097/00000478-200503000-00014. View

15.

Chu D, Erickson C, Russell M, Thompson C, Lang N, Broadwater R . Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence. Arch Surg. 1991; 126(3):314-6. DOI: 10.1001/archsurg.1991.01410270054010. View